Ligand Pharmaceuticals (LGND) Current Taxes (2019 - 2026)
Ligand Pharmaceuticals recorded quarterly Current Taxes of $1.9 million in Q1 2026, up 52.78% quarter-over-quarter from $1.2 million in Q4 2025, and up 4.99% year-over-year from $1.8 million in Q1 2025.
Ligand Pharmaceuticals' Current Taxes history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Current Taxes rose 4.99% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 4.99% YoY), while the FY2025 annual figure was $1.2 million, up 3.34% from the prior year.
- Current Taxes came in at $1.9 million for Q1 2026 at Ligand Pharmaceuticals, up from $1.2 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $11.4 million in Q2 2023 to a low of $305000.0 in Q2 2025.
- A 5-year average of $3.2 million and a median of $1.8 million in 2025 frame the typical range for Current Taxes.
- On a YoY basis, Current Taxes climbed as much as 201.08% in 2023 and fell as far as 87.59% in 2023.
- Ligand Pharmaceuticals' Current Taxes stood at $9.7 million in 2022, then sank by 87.59% to $1.2 million in 2023, then retreated by 0.42% to $1.2 million in 2024, then advanced by 3.34% to $1.2 million in 2025, then surged by 52.78% to $1.9 million in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $1.9 million, $1.2 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn | 1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 305,000.00 |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 11.39 Mn |
| Sep 30, 2022 | 9.70 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.80 Mn |
| Sep 30, 2020 | 674,000.00 |
| Sep 30, 2019 | 16.57 Mn |
| Jun 30, 2019 | 47.46 Mn |
| Mar 31, 2019 | 114.00 Mn |